Becton Dickinson Insider Garrison David Buys 3,054 Shares Amid FDA Clearance Boost, Sending Mixed Signals to Investors
Insider buying by Becton Dickinson’s EVP signals cautious optimism: a strategic 3,054‑share purchase amid FDA clearance of EnCompass and a bullish pipeline.
4 minutes to read